A growing body of studies suggests that NF-kB activation mediates up-regulation of inflammatory cytokines, angiogenic factors (e.g. CRP, IL-6, TNF-α, IL-1β, VEGF, MMP-9) in cancer [41,65–69]. The gene discussed is IL6; the disease is cancer.